Top compounds associated with response to CLEC9A


Feature Type Standardized
Nominal ANOVA
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA cabozantinib CTRPv2 pan-cancer AAC -0.032 0.4
mRNA (5Z)-7-Oxozeaenol GDSC1000 pan-cancer AAC 0.027 0.4
mRNA BRD-K61166597 CTRPv2 pan-cancer AAC 0.028 0.4
mRNA selumetinib:PLX-4032 (8:1 mol/mol) CTRPv2 pan-cancer AAC 0.031 0.4
mRNA BRD-K80183349 CTRPv2 pan-cancer AAC 0.028 0.4
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC 0.03 0.4
mRNA Bryostatin 1 GDSC1000 pan-cancer AAC -0.03 0.4
mRNA KU-55933 CTRPv2 pan-cancer AAC 0.031 0.4
mRNA tamatinib CTRPv2 pan-cancer AAC -0.032 0.4
Download CSV